1 Introduction to Research & Analysis Reports 1.1 Corticosteroid Nasal Spray Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Corticosteroid Nasal Spray Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Corticosteroid Nasal Spray Overall Market Size 2.1 United States Corticosteroid Nasal Spray Market Size: 2021 VS 2027 2.2 United States Corticosteroid Nasal Spray Revenue, Prospects & Forecasts: 2016-2027 2.3 United States Corticosteroid Nasal Spray Sales: 2016-2027 3 Company Landscape 3.1 Top Corticosteroid Nasal Spray Players in United States Market 3.2 Top United States Corticosteroid Nasal Spray Companies Ranked by Revenue 3.3 United States Corticosteroid Nasal Spray Revenue by Companies 3.4 United States Corticosteroid Nasal Spray Sales by Companies 3.5 United States Corticosteroid Nasal Spray Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Corticosteroid Nasal Spray Companies in United States Market, by Revenue in 2020 3.7 Manufacturers Corticosteroid Nasal Spray Product Type 3.8 Tier 1, Tier 2 and Tier 3 Corticosteroid Nasal Spray Players in United States Market 3.8.1 List of Tier 1 Corticosteroid Nasal Spray Companies in United States 3.8.2 List of Tier 2 and Tier 3 Corticosteroid Nasal Spray Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Corticosteroid Nasal Spray Market Size Markets, 2021 & 2027 4.1.2 Azelastine and Fluticasone Propionate 4.1.3 Diproprionate (Dry nasal spray) 4.1.4 Budesonide 4.1.5 Others 4.2 By Type - United States Corticosteroid Nasal Spray Revenue & Forecasts 4.2.1 By Type - United States Corticosteroid Nasal Spray Revenue, 2016-2021 4.2.2 By Type - United States Corticosteroid Nasal Spray Revenue, 2022-2027 4.2.3 By Type - United States Corticosteroid Nasal Spray Revenue Market Share, 2016-2027 4.3 By Type - United States Corticosteroid Nasal Spray Sales & Forecasts 4.3.1 By Type - United States Corticosteroid Nasal Spray Sales, 2016-2021 4.3.2 By Type - United States Corticosteroid Nasal Spray Sales, 2022-2027 4.3.3 By Type - United States Corticosteroid Nasal Spray Sales Market Share, 2016-2027 4.4 By Type - United States Corticosteroid Nasal Spray Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Corticosteroid Nasal Spray Market Size, 2021 & 2027 5.1.2 Hospital 5.1.3 Drug Store 5.1.4 Clinics 5.1.5 Others 5.2 By Application - United States Corticosteroid Nasal Spray Revenue & Forecasts 5.2.1 By Application - United States Corticosteroid Nasal Spray Revenue, 2016-2021 5.2.2 By Application - United States Corticosteroid Nasal Spray Revenue, 2022-2027 5.2.3 By Application - United States Corticosteroid Nasal Spray Revenue Market Share, 2016-2027 5.3 By Application - United States Corticosteroid Nasal Spray Sales & Forecasts 5.3.1 By Application - United States Corticosteroid Nasal Spray Sales, 2016-2021 5.3.2 By Application - United States Corticosteroid Nasal Spray Sales, 2022-2027 5.3.3 By Application - United States Corticosteroid Nasal Spray Sales Market Share, 2016-2027 5.4 By Application - United States Corticosteroid Nasal Spray Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Overview 6.1.3 Pfizer Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.1.4 Pfizer Corticosteroid Nasal Spray Product Description 6.1.5 Pfizer Recent Developments 6.2 Aegis Therapeutics 6.2.1 Aegis Therapeutics Corporation Information 6.2.2 Aegis Therapeutics Overview 6.2.3 Aegis Therapeutics Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.2.4 Aegis Therapeutics Corticosteroid Nasal Spray Product Description 6.2.5 Aegis Therapeutics Recent Developments 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Overview 6.3.3 GlaxoSmithKline Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.3.4 GlaxoSmithKline Corticosteroid Nasal Spray Product Description 6.3.5 GlaxoSmithKline Recent Developments 6.4 Kurve Technology 6.4.1 Kurve Technology Corporation Information 6.4.2 Kurve Technology Overview 6.4.3 Kurve Technology Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.4.4 Kurve Technology Corticosteroid Nasal Spray Product Description 6.4.5 Kurve Technology Recent Developments 6.5 Marina Biotech 6.5.1 Marina Biotech Corporation Information 6.5.2 Marina Biotech Overview 6.5.3 Marina Biotech Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.5.4 Marina Biotech Corticosteroid Nasal Spray Product Description 6.5.5 Marina Biotech Recent Developments 6.6 Merck 6.6.1 Merck Corporation Information 6.6.2 Merck Overview 6.6.3 Merck Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.6.4 Merck Corticosteroid Nasal Spray Product Description 6.6.5 Merck Recent Developments 6.7 OptiNose 6.7.1 OptiNose Corporation Information 6.7.2 OptiNose Overview 6.7.3 OptiNose Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.7.4 OptiNose Corticosteroid Nasal Spray Product Description 6.7.5 OptiNose Recent Developments 6.8 Sanofi 6.8.1 Sanofi Corporation Information 6.8.2 Sanofi Overview 6.8.3 Sanofi Corticosteroid Nasal Spray Sales and Revenue in United States Market (2016-2021) 6.8.4 Sanofi Corticosteroid Nasal Spray Product Description 6.8.5 Sanofi Recent Developments 7 United States Corticosteroid Nasal Spray Production Capacity, Analysis 7.1 United States Corticosteroid Nasal Spray Production Capacity, 2016-2027 7.2 Corticosteroid Nasal Spray Production Capacity of Key Manufacturers in United States Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Corticosteroid Nasal Spray Supply Chain Analysis 9.1 Corticosteroid Nasal Spray Industry Value Chain 9.2 Corticosteroid Nasal Spray Upstream Market 9.3 Corticosteroid Nasal Spray Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Corticosteroid Nasal Spray Distributors and Sales Agents in United States Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Corticosteroid Nasal Spray in United States Market Table 2. Top Corticosteroid Nasal Spray Players in United States Market, Ranking by Revenue (2019) Table 3. United States Corticosteroid Nasal Spray Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Corticosteroid Nasal Spray Revenue Share by Companies, 2016-2021 Table 5. United States Corticosteroid Nasal Spray Sales by Companies, (K Units), 2016-2021 Table 6. United States Corticosteroid Nasal Spray Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Corticosteroid Nasal Spray Price (2016-2021) & (USD/Unit) Table 8. Manufacturers Corticosteroid Nasal Spray Product Type Table 9. List of Tier 1 Corticosteroid Nasal Spray Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Corticosteroid Nasal Spray Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Azelastine and Fluticasone Propionate Table 12. Major Manufacturers of Diproprionate (Dry nasal spray) Table 13. By Type – United States Corticosteroid Nasal Spray Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Corticosteroid Nasal Spray Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Corticosteroid Nasal Spray Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Corticosteroid Nasal Spray Sales (K Units), 2016-2021 Table 17. By Type - United States Corticosteroid Nasal Spray Sales (K Units), 2022-2027 Table 18. By Application – United States Corticosteroid Nasal Spray Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Corticosteroid Nasal Spray Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Corticosteroid Nasal Spray Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Corticosteroid Nasal Spray Sales (K Units), 2016-2021 Table 22. By Application - United States Corticosteroid Nasal Spray Sales (K Units), 2022-2027 Table 23. Pfizer Corporation Information Table 24. Pfizer Description and Major Businesses Table 25. Pfizer Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 26. Pfizer Corticosteroid Nasal Spray Product Table 27. Pfizer Recent Developments Table 28. Aegis Therapeutics Corporation Information Table 29. Aegis Therapeutics Description and Major Businesses Table 30. Aegis Therapeutics Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 31. Aegis Therapeutics Corticosteroid Nasal Spray Product Table 32. Aegis Therapeutics Recent Developments Table 33. GlaxoSmithKline Corporation Information Table 34. GlaxoSmithKline Description and Major Businesses Table 35. GlaxoSmithKline Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 36. GlaxoSmithKline Corticosteroid Nasal Spray Product Table 37. GlaxoSmithKline Recent Developments Table 38. Kurve Technology Corporation Information Table 39. Kurve Technology Description and Major Businesses Table 40. Kurve Technology Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 41. Kurve Technology Corticosteroid Nasal Spray Product Table 42. Kurve Technology Recent Developments Table 43. Marina Biotech Corporation Information Table 44. Marina Biotech Description and Major Businesses Table 45. Marina Biotech Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 46. Marina Biotech Corticosteroid Nasal Spray Product Table 47. Marina Biotech Recent Developments Table 48. Merck Corporation Information Table 49. Merck Description and Major Businesses Table 50. Merck Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 51. Merck Corticosteroid Nasal Spray Product Table 52. Merck Recent Developments Table 53. OptiNose Corporation Information Table 54. OptiNose Description and Major Businesses Table 55. OptiNose Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 56. OptiNose Corticosteroid Nasal Spray Product Table 57. OptiNose Recent Developments Table 58. Sanofi Corporation Information Table 59. Sanofi Description and Major Businesses Table 60. Sanofi Corticosteroid Nasal Spray Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 61. Sanofi Corticosteroid Nasal Spray Product Table 62. Sanofi Recent Developments Table 63. Corticosteroid Nasal Spray Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units) Table 64. United States Corticosteroid Nasal Spray Capacity Market Share of Key Manufacturers, 2019-2021 Table 65. Corticosteroid Nasal Spray Market Opportunities & Trends in United States Market Table 66. Corticosteroid Nasal Spray Market Drivers in United States Market Table 67. Corticosteroid Nasal Spray Market Restraints in United States Market Table 68. Corticosteroid Nasal Spray Raw Materials Table 69. Corticosteroid Nasal Spray Raw Materials Suppliers in United States Market Table 70. Typical Corticosteroid Nasal Spray Downstream Table 71. Corticosteroid Nasal Spray Downstream Clients in United States Market Table 72. Corticosteroid Nasal Spray Distributors and Sales Agents in United States Market List of Figures Figure 1. Corticosteroid Nasal Spray Product Picture Figure 2. Corticosteroid Nasal Spray Segment by Type Figure 3. Corticosteroid Nasal Spray Segment by Application Figure 4. United States Corticosteroid Nasal Spray Market Overview: 2020 Figure 5. United States Corticosteroid Nasal Spray Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Corticosteroid Nasal Spray Revenue, 2016-2027 (US$, Mn) Figure 7. Corticosteroid Nasal Spray Sales in United States Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Corticosteroid Nasal Spray Revenue in 2020 Figure 9. Azelastine and Fluticasone Propionate Product Picture Figure 10. Diproprionate (Dry nasal spray) Product Picture Figure 11. Budesonide Product Picture Figure 12. Others Product Picture Figure 13. By Type - United States Corticosteroid Nasal Spray Sales Market Share, 2016-2027 Figure 14. By Type - United States Corticosteroid Nasal Spray Revenue Market Share, 2016-2027 Figure 15. By Type - United States Corticosteroid Nasal Spray Price (USD/Unit), 2016-2027 Figure 16. Hospital Figure 17. Drug Store Figure 18. Clinics Figure 19. Others Figure 20. By Application - United States Corticosteroid Nasal Spray Sales Market Share, 2016-2027 Figure 21. By Application - United States Corticosteroid Nasal Spray Revenue Market Share, 2016-2027 Figure 22. By Application - United States Corticosteroid Nasal Spray Price (USD/Unit), 2016-2027 Figure 23. Pfizer Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Aegis Therapeutics Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. GlaxoSmithKline Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Kurve Technology Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Marina Biotech Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Merck Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. OptiNose Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Sanofi Corticosteroid Nasal Spray Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. United States Corticosteroid Nasal Spray Production Capacity (K Units), 2016-2027 Figure 32. Corticosteroid Nasal Spray Industry Value Chain Figure 33. Marketing Channels

Pfizer Aegis Therapeutics GlaxoSmithKline Kurve Technology Marina Biotech Merck OptiNose Sanofi